Nicolai J. Wewer Albrechtsen

Excited to share our review on #glucagon Super fun collab with #Jensholst #alancherrington @brianfinan #liselottegluud @deanlab8 @JCampbellLab @Filip_Knop @TimoMueller_IDO Multiple institutions from #Europe and the #US @UCPH_health @bfhosp @helmholtz_diabc @novonordisk ++++

🎙️Join authors Anne-Sofie H. Jensen and Nicolai J. Wewer Albrechtsen as they discuss fascinating research on glucose disturbances in #AutoimmuneLiverDisease! 🔗ow.ly/P3es50Tx7B5 @nicwin98 #AutoimmuneHepatitis #diabetes #incretin

Congratulations to Nicolai Wever Albrechtsen on receiving the prestigious Anders Jahre Prize for 2024 for young scientists! His groundbreaking work in glucagon regulation and plasma proteomics continues to advance our understanding of health and disease. uio.no/english/about/…

The GLUSENTIC test and index assessing dynamic amino acid responses to glucagon may be used to measure glucagon resistance in individuals with #obesity and #MASLD @Diabetes_ADA @Metabolcenter diabetesjournals.org/diabetes/artic…

For millennia, migraine's origin puzzled scientists. We contributed to the @ScienceMagazine paper showing how cortical spreading depression alters 11% of CSF proteome, including 2-fold increase in CGRP. The proteomic shift may explain aura-headache link. @nicwin98 @NedergaardLab

@EASDnews @Metabolcenter @JuleenRZierath @novonordiskfond @professorcm @karolinskainst @uni_copenhagen Congratulations @JuleenRZierath 👏🏻

Congratulations to Juleen Zierath who is the recipient of the EASD-Novo Nordisk Foundation Diabetes Prize for Excellence 2024! 👏 @JuleenRZierath receives the award at #EASD2024 in Madrid to recognise her outstanding achievements in #diabetes #research. @novonordiskfond

@Filip_Knop @mariewin3 @DiabetologiaJnl @liselottegluud @s_brunak @MetteRosenkild1 @UCPH_health @UCPH_Research @koebenhavns_uni @HerlevGentofte @Stenodiabetes @novonordiskfond Thanks for the collaboration! It was fun as always

Determinants of plasma levels of proglucagon and the metabolic impact of glucagon receptor signalling: a UK Biobank study Congrats to @mariewin3 and @nicwin98 and team for publishing this piece in @DiabetologiaJnl 👌🤩👏 link.springer.com/article/10.100…

@DanielJDrucker @UTSWdiabetes @Cell_Metabolism Really nice work! Congrats We hopefully can share our findings from using pharmacological tools to investigate renal effects 🤟🏻

Here May Wang in the Scherer lab @UTSWdiabetes comprehensively interrogates loss of renal glucagon action in mice revealing heretofore underappreciated metabolic, structural and functional roles of the kidney GCGR @Cell_Metabolism #T2D #diabetes #obesity cell.com/cell-metabolis…

Glucagon and the kidney-interesting, important, irrelevant? journals.physiology.org/doi/full/10.11…

@AJPEndoMetab @YounesAnini @APSPublications Thank you and happy to support science in #endocrinology and #physiology @bfhosp

Congratulations to our @AJPEndoMetab Star Reviewers! ⭐️ -Dr. Nicolai Wewer Albrechtsen (University of Copenhagen) -Dr. Eugene Barrett (University of Virginia, School of Medicine) -Dr. Younes Anini (Dalhousie University) @nicwin98 @YounesAnini @APSPublications

#Glucagon resistance exist in #MASLD but can this be reversed by reducing hepatic steatosis alone or by weight loos? @KjeldsenSasha at @bfhosp investigated this in patients with type 2 diabetes. #obesity and not MASLD may be dictating #glucagonresistance academic.oup.com/jes/advance-ar…

Gene environment interactions and the risk of coronary artery disease #Genetics @CellCellPress cell.com/cell/fulltext/…

The collaboration has been done by #AnneSophieHoulberg and our close friends at @AmagerHvidovre @liselottegluud #HenrietteYtting and #JohanBurisch and #AnnikaBergquist @karolinskainst @bfhosp @UCPH_health @UCPH_CPR

#NAFLD increases the risk of diabetes but what is known about rare but seriost chronic liver diseases like #autoimmune liver disease? We have for the last 3 years explored this by literature review, metaanalysis and clinical studies. Here our first take pubmed.ncbi.nlm.nih.gov/37505973/

Up front & free to read in our Aug issue #editorspicks: 100 years of glucagon and 100 more tinyurl.com/48rv8ftf

@karenvallgarda @livaaben Vild spændende at få disse perspektiver om familien 👌🏻

@DiabetologiaJnl @hinmul Thank you for selecting our piece on #glucagon pubmed.ncbi.nlm.nih.gov/37367959/

Our editor @hinmul highlights 5 papers, all free to read, from our August issue! link.springer.com/article/10.100…

Review on 100 years of #glucagon, covering: -Its secretion and actions, -Its role in metabolic diseases, -Glucagon pharmacology. @nicwin98 #JensHolst @deanlab8 @JCampbellLab #TriciaTan @Filip_Knop @TimoMueller_IDO tinyurl.com/48rv8ftf

@novonordiskfond Many congratulations to all in particular @NikolajRittig and @GasbjergL 👏🏻👌🏻 look forward to followup all these exciting projects

The Novo Nordisk Foundation has awarded 37 new grants through its major Research Leader Programme that supports leading researchers at different career stages. More than 200 researchers have now received grants through the Programme. novonordiskfonden.dk/en/news/novo-n…

@rbdamgaard Stort tillykke 👌🏻👍🏻

Tusinde tak til DFF for at støtte vores helt og aldeles ikke-missions-drevne, nysgerrighedsbaserede grundforskning. Det er jeg meget glad for, man stadig kan få penge til. #dkforsk

Thoughtful and excellent perspective on the issues raised by the unexpected closing of the CPR in Copenhagen by the Novo Nordisk Foundation. Its by our international SAB under the leadership of Angus Lamond. Out in EMBO Reports now. embopress.org/doi/epdf/10.15…